Efficacy of add on therapy of Vildagliptin versus Pioglitazone in inadequately controlled Type 2 Diabetes Mellitus patients on dual therapy of Metformin plus Sulfonylurea

Trial Profile

Efficacy of add on therapy of Vildagliptin versus Pioglitazone in inadequately controlled Type 2 Diabetes Mellitus patients on dual therapy of Metformin plus Sulfonylurea

Completed
Phase of Trial: Phase II

Latest Information Update: 24 Aug 2016

At a glance

  • Drugs Pioglitazone (Primary) ; Metformin; Sulfonylureas; Vildagliptin
  • Indications Type 2 diabetes mellitus
  • Focus Therapeutic Use
  • Most Recent Events

    • 24 Jul 2013 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top